Revvity Inc. $RVTY Shares Purchased by Prudential Financial Inc.

Prudential Financial Inc. grew its position in Revvity Inc. (NYSE:RVTY) by 145.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 180,533 shares of the company’s stock after purchasing an additional 106,901 shares during the period. Prudential Financial Inc. owned approximately 0.16% of Revvity worth $17,461,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the company. UMB Bank n.a. boosted its position in shares of Revvity by 138.8% during the second quarter. UMB Bank n.a. now owns 406 shares of the company’s stock worth $39,000 after buying an additional 236 shares during the period. CVA Family Office LLC increased its position in Revvity by 79.0% in the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company’s stock valued at $40,000 after acquiring an additional 181 shares during the period. New Age Alpha Advisors LLC bought a new stake in Revvity during the 1st quarter valued at $44,000. Caitong International Asset Management Co. Ltd boosted its position in Revvity by 25.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company’s stock worth $73,000 after acquiring an additional 140 shares during the period. Finally, Cary Street Partners Investment Advisory LLC acquired a new position in Revvity during the 1st quarter worth $75,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Price Performance

Shares of NYSE RVTY opened at $104.76 on Thursday. Revvity Inc. has a twelve month low of $81.36 and a twelve month high of $128.29. The company has a current ratio of 1.75, a quick ratio of 2.75 and a debt-to-equity ratio of 0.36. The firm has a 50-day moving average of $92.55 and a two-hundred day moving average of $92.53. The company has a market capitalization of $11.88 billion, a price-to-earnings ratio of 52.64, a PEG ratio of 3.15 and a beta of 1.01.

Revvity (NYSE:RVTY) last released its earnings results on Monday, October 27th. The company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.14 by $0.04. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The business had revenue of $698.95 million for the quarter, compared to the consensus estimate of $699.75 million. During the same period in the previous year, the firm earned $1.28 EPS. The business’s revenue for the quarter was up 2.2% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. As a group, analysts expect that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 6th. Stockholders of record on Friday, January 16th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Friday, January 16th. Revvity’s dividend payout ratio is 14.07%.

Revvity declared that its Board of Directors has initiated a share buyback program on Monday, October 27th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 8.7% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s leadership believes its stock is undervalued.

Analyst Ratings Changes

RVTY has been the topic of a number of research analyst reports. Barclays raised their price target on Revvity from $100.00 to $105.00 and gave the company an “overweight” rating in a report on Tuesday, October 28th. Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a research report on Sunday, August 3rd. Weiss Ratings reissued a “sell (d)” rating on shares of Revvity in a research note on Tuesday. Robert W. Baird upped their price target on shares of Revvity from $122.00 to $123.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 28th. Finally, Evercore ISI reiterated an “outperform” rating and issued a $108.00 price objective on shares of Revvity in a report on Monday, October 27th. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $114.75.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.